International Journal of Biotechnology and Recent Advances

ISSN: 2639-4529

International Biotechnology and Research Conference
April 25-27, 2018 Rome, Italy

Native Cell Membrane Nanoparticles System for Membrane Proteins

Youzhong Guo1, 2*, Weihua Qiu1,2, Ziao Fu3, Guoyan G. Xu1, Robert A. Grassucci4, Yan Zhang1, Joachim Frank4,5 and Wayne A. Hendrickson4,6,7

1Department of Medicinal Chemistry, Virginia Commonwealth University, USA
2Institute for Structural Biology, Virginia Commonwealth University, USA
3Integrated Program in Cellular, Molecular, and Biomedical Studies, Columbia University, USA
4Department of Biochemistry and Molecular Biophysics, Columbia University, USA
5Department of Biological Sciences, Columbia University, USA
6Department of Physiology and Cellular Biophysics, Columbia University, USA
7New York Structural Biology Center, USA

DOI: 10.18689/2639-4529.a1.002

Download PDF

We devised a native cell membrane nanoparticles system, which we applied in a single-particle cryo-EM study of the multidrug exporter AcrB. Lipid-AcrB nanoparticles were prepared directly from membranes without any use of detergents. A 3D reconstruction in C1 symmetry achieved a final density map at 3.2 Å resolution, an atomic model of quasi-C3-symmetric AcrBwas fitted to this map, and the residual density revealed many ordered lipid molecules. Most remarkably, a central cavity between the three transmembrane domains contains a 24-lipid patch of well-ordered bilayer structure. Inner leaflet lipid chains pack in a hexagonal array like that in phosphatidylethanolamine crystal structures, whereas the outer leaflet has highly irregular packing. Protein side chains interact with both leaflets and participate in the hexagonal pattern. The AcrB export mechanism requires reorganization of the lipid bilayer structure. This system should be broadly applicable for membrane protein structural biology and structure-based drug discovery and development.

Youzhong Guo was born in Xiangcheng, Henan, China, in 1974. He received the B.S. degree in biology from Henan Normal University, Xinxiang, Henan, China, in 1997. He received the Ph.D. degree in pharmacy/structural biology from the University of Texas at Austin, Austin, TX, U.S.A., in 2010. From 2010 to 2016, he worked with Dr. Wayne A. Hendrickson as a postdoc in Columbia University, New York, NY, U.S.A. In 2016, he joined the Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, VA, U.S.A. as an Assistant Professor. His current research interests include membrane protein structural biology and structure-based drug discovery.